Weight-loss drug users save more than £400 a year on food as take-up triples
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- GLP-1 users increased from 2.3% of UK households in 2024 to 6.3% now, more than doubling the share in two years.
- Worldpanel by Numerator found that households with a GLP‑1 user spent £780 million less on groceries in the year after starting the medication, equating to a £418 per‑household drop versus non‑users.
- GLP-1 users reported cutting back on treats, with 75% eating less chocolate and 72% reducing crisps, and chocolate confectionery spend fell 18 percentage points more than in non‑user households.
- Marks & Spencer introduced a “nutrient‑dense” range aimed at customers eating less, while Ocado launched a virtual “weight‑management” aisle for GLP‑1 users.
- GLP-1 users said 41% stopped the medication in 2026 because of cost, making price the primary barrier to continued use.
Why it matters: Consumers on GLP‑1 drugs are cutting grocery bills by an average of £418 per household, while retailers are scrambling to offer low‑calorie and “weight‑management” products; meanwhile, the high cost of the medication forces 41% of users to stop, highlighting a cost barrier for a growing market.
